Vanessa Fontana

DC isoketal-modified proteins activate T cells and promote hypertension

Annet Kirabo, Vanessa Fontana, Ana Paula de Faria et al. · Journal of Clinical Investigation · 2014 · 522 citations · Full text

Hypertension, Dendritic Cell, T-regulatory Cell +25

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase‐2 activity and expression in a model of renovascular hypertension

Élen Rizzi, M.M. Montenegro, Vanessa Fontana et al. · British Journal of Pharmacology · 2010 · 105 citations · Full text

Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers

Natália R. Barbaro, Vanessa Fontana, Rodrigo Modolo et al. · Blood Pressure · 2014 · 104 citations

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity

F. Di Pisa, Giacomo Landi, Lucia Dello Iacono et al. · Molecules · 2017 · 64 citations · Full text